Genetic Technologies Ownership
| GTG Stock | 0.04 0.00 0.00% |
Shares in Circulation | First Issued 2004-09-30 | Previous Quarter 120.8 M | Current Value 149 M | Avarage Shares Outstanding 1.1 B | Quarterly Volatility 3 B |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Genetic |
Genetic Stock Ownership Analysis
The book value of the company was currently reported as 0.01. The company had not issued any dividends in recent years. Genetic Technologies had 1:100 split on the 14th of December 3124. To learn more about Genetic Technologies call the company at 61 3 8412 7000 or check out https://genetype.com.Genetic Technologies Outstanding Bonds
Genetic Technologies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Genetic Technologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Genetic bonds can be classified according to their maturity, which is the date when Genetic Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Genetic Stock Analysis
When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.